On December 9, 2020, each of Erez Chimovits and Daniel O'Connell informed the Board of Directors of LogicBio Therapeutics, Inc. that he would resign as a director of the Company, effective December 10, 2020. On December 10, 2020, the Board appointed Jeff Goater to serve as a Class I director for a term expiring at the Company's 2022 annual meeting of the stockholders or upon his earlier death, resignation or removal and Daphne Karydas to serve as a Class II director for a term expiring at the Company's 2023 annual meeting of the stockholders or upon her earlier death, resignation or removal. The Board also appointed Mr. Goater and Ms. Karydas to serve as a member of the Board's Compensation Committee and Audit Committee, respectively. Mr. Goater and Ms. Karydas will be compensated for their service as directors in accordance with the Company's non-employee director compensation policy, as generally described in the Company's definitive proxy statement on Schedule 14A, as filed with the Securities and Exchange Commission on April 29, 2020.